Can Calumet (CLMT) Turn Surging Revenue Into a Sustainable Path Out of Persistent Losses?

• In the past quarter, Calumet, Inc. reported second-quarter 2026 sales of US$1,445.1 million versus US$1,026.6 million a year earlier, with net loss improving to US$95.9 million from US$147.9 million, while first-half 2026 sales reached US$2,474.9 million and net loss widened to US$412.9 million compared with US$309.9 million a year ago.

• The results highlight a complex picture of higher revenue but continued losses, underscoring the tension between Calumet's growth ambitions and the profitability challenges it still faces.

• With earnings revealing higher sales but persistent losses and oil prices supported by geopolitical tensions, we'll assess how this reshapes Calumet's investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Calumet Investment Narrative Recap

To own Calumet today, you need to believe that its mix of specialty products and renewables can eventually offset persistent losses and a stretched balance sheet. The short term catalyst is still the ramp and profitability of Montana Renewables and the MaxSAF 150 rollout, while the biggest risk remains Calumet's high leverage and sensitivity to margins. Recent earnings and the oil price driven share move do not yet materially change that risk reward balance.

The most relevant recent announcement here is Calumet's July 2026 move to redeem US$100.0 million of 9.75% Senior Notes due 2028 at a premium. This step simplifies the capital structure but also highlights how dependent the story is on access to reasonably priced debt, especially if operating losses continue and margin support from regulation or oil markets weakens.

Yet behind the share price rally, one risk investors should be acutely aware of is Calumet's substantial debt load and what happens if...

Read the full narrative on Calumet (it's free!)

Calumet's narrative projects $5.3 billion revenue and $226.9 million earnings by 2029.

Uncover how Calumet's forecasts yield a $38.80 fair value , a 18% downside to its current price.

Exploring Other Perspectives

While recent oil driven optimism helps, the lowest tier of analysts still saw a tougher road, with only about US$4.2 billion of revenue and roughly US$142 million of earnings by 2029, suggesting you consider how their more cautious view on regulation and financing risk might shift in light of this latest news.

Explore 2 other fair value estimates on Calumet - why the stock might be worth as much as 27% more than the current price!